Policy and Regulation
Nanomedicines Alliance
1500 K Street NW, Ste. 1100
Washington, DC
20005
USA
As the only industry group in existence that focuses on the scientific and regulatory aspects and policy needs of nanomedicines, the Alliance has the following vision and mission:
Vision
To catalyze the use of nanomedicines for patient benefit.
Mission
To promote and facilitate the scientific advancement, regulatory approval, safe use and public appreciation of nanotechnology-based medicines world-wide for the diagnosis, treatment and prevention of disease.